Source: OINDPnews

CoreRx: CoreRx adds particle engineering capabilities with Bend Bioscience deal

According to early stage CDMO Bend Bioscience, the company is now part of Florida-based CDMO CoreRx thanks to an equity investment by NovaQuest Private Equity, which acquired CoreRx in 2021. Bend Bioscience, which launched in 2021, will offer particle engineering and manufacturing services for a range of dosage forms, including dry powders for inhalation. Bend [...]

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Owen Murray's photo - CEO of CoreRx

CEO

Owen Murray

CEO Approval Rating

82/100

Read more